Cardiac Safety Services Market to Reach $1.75 Billion by 2029, Expanding at 10.7% CAGR

 Tailored for companies operating in or entering the cardiac safety services sector, this analysis highlights core growth drivers, risks, and innovation trends.

 

 What Is The Expected CAGR For The Cardiac Safety Services Market Through 2025?
 The cardiac safety services market size has grown strongly in recent years. It will grow from $1.06 billion in 2024 to $1.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to drug development and clinical trials, regulatory compliance requirements, increased cardiovascular disorders, globalization of clinical trials, focus on personalized medicine.
 
 The cardiac safety services market size is expected to see rapid growth in the next few years. It will grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to remote patient monitoring, shift towards decentralized clinical trials, rise in orphan drug development, increasing outsourcing of clinical trials, regulatory emphasis on patient-centric approaches. Major trends in the forecast period include integration of wearable technologies, advancements in ECG technologies, decentralized clinical trials, data standardization and interoperability, telehealth and remote consultations, patient-centric approaches.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=10137&type=smp
 
 Which Key Factors Will Influence Cardiac Safety Services Market Growth Over 2025–2034?
 The increase in the prevalence of cardiovascular diseases is expected to propel the growth of the cardiac safety services market going forward. Cardiovascular diseases refer to a group of disorders that affect the heart and blood vessels, such as peripheral arterial disease, cerebrovascular disease, coronary heart disease, and others. Cardiac safety services deal with heart health and safety monitoring, determining factors contributing to cardiovascular disease before disease occurrence, thereby helping in taking preventative measures and reducing the chance of mortality. For instance, in March 2023, according to the journal published by Oxford University Press, a UK-based university press of the University of Oxford, more than 200 million people were affected by peripheral artery diseases in 2020, and it was expected to increase by nearly 50% by 2045. Furthermore, for instance, in September 2024, according to the data published by the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Therefore, the increase in the prevalence of cardiovascular diseases is driving the growth of the cardiac safety services market. 
 
 Comprehensive Segment-Wise Insights Into The Cardiac Safety Services Market
 The cardiac safety servicesmarket covered in this report is segmented — 
 
 1) By Services: ECG Or Holter Measurements; Blood Pressure Measurements; In Vitro Cardiac Safety Assessment Services; Cardiovascular Imaging; Real-Time Telemetry Monitoring; Central Over-Read Of ECGS; Non-Invasive Cardiac Imaging; Physiologic Stress Testing; Thorough QT Studies; Other services 
 2) By Phase: Phase 1; Phase 2; Phase 3
 3) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Research Organizations; Academic and Research Institute
 
 Subsegments:
 1) By ECG Or Holter Measurements: Standard ECG Monitoring; 24-Hour Holter Monitoring; Event Monitoring
 2) By Blood Pressure Measurements: Continuous Blood Pressure Monitoring; Ambulatory Blood Pressure Monitoring; In-Hospital Blood Pressure Measurements
 3) By In Vitro Cardiac Safety Assessment Services: Cardiomyocyte Toxicity Testing; Cardiac Ion Channel Testing; Mechanistic Studies
 4) By Cardiovascular Imaging: Echocardiography; MRI Imaging; CT Angiography
 5) By Real-Time Telemetry Monitoring: Remote Patient Monitoring; Continuous Telemetry Services
 6) By Central Over-Read Of ECGs: ECG Interpretation Services; Quality Control And Reporting
 7) By Non-Invasive Cardiac Imaging: Stress Testing; Nuclear Cardiology
 8) By Physiologic Stress Testing: Exercise Stress Testing; Pharmacologic Stress Testing
 9) By Thorough QT Studies: Clinical Trial Services; Safety Assessments For Drug Development
 10) By Other Services: Cardiac Device Monitoring; Clinical Consultation Services
 
 What Are The Prominent Trends In The Cardiac Safety Services Market?
 Product innovations are a key trend gaining popularity in the cardiac safety services market. Major companies operating in the cardiac safety services market are focused on developing new solutions to strengthen their position in the market. For instance, in March 2022, CATHI, a Germany-based technology-driven company that develops endovascular simulation technologies launched CATHIS RHC 2, a new generation of Right Heart Catheter (RHC) simulators. CATHIS RHC 2 is an updated version and incorporates all the features of CATHI’s original RHC simulator, with wire-assisted navigation and the potential to work with real liquids (S-HUB) as the additional benefits that allow thermodilution to be performed.
 
 Analysis Of Key Players In Cardiac Safety Services Market
 Major companies operating in the cardiac safety services market include Laboratory Corporation of America Holdings, Banook Group Limited, Pharmaceutical Product Development LLC, Biotrial S.A., Certara Inc., Celerion Inc., Medpace Holdings Inc., Ncardia AG, Richmond Pharmacology Limited, PhysioStim, SGS Société Générale de Surveillance SA, Koninklijke Philips N.V., Clario, NEXEL Co. Ltd., Eurofins Scientific SE, InBody USA Inc., Spaulding Clinical Research LLC, OMRON Healthcare Inc., ERT Inc., IQVIA Holdings Inc., Bioclinica Inc., ICON plc, BioTelemetry Inc., Medidata Solutions Inc., SYNEXUS Clinical Research, PPD Inc., Parexel International Corporation, Chiltern International Limited, ACI Clinical Inc., Biomedical Systems, High Point Clinical Trials Center, Maastricht University Medical Centre+, CCBR-SYNARC, Cytel Inc., CardioSecur Ltd., Medicalgorithmics S.A., Advarra Inc. 
 
 View the full cardiac safety services market report here:
 https://www.thebusinessresearchcompany.com/report/cardiac-safety-services-global-market-report
 
 What Are The Key Regional Trends In The Cardiac Safety Services Market?
 North America was the largest region in the cardiac safety services market in 2024. The regions covered in the cardiac safety services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company